Gareth Jones

Gareth Jones is the interim CEO of Tissue Regenix. Gareth was previously the CFO of Applied Graphene Materials from April 2017 to October 2018. Prior to that, they were the finance director of Emco Wheaton - A Gardner Denver Product from September 2013 to March 2017. Jones also served as the director of Vireol plc from October 2006 to September 2013, and as the European FD of Gardner Denver from November 2003 to November 2006. Their earliest experience in finance was as the group FC of syltone from November 1997 to November 2004.

Gareth Jones completed their undergraduate degree in engineering at the University of Nottingham. Gareth then went on to study at Harrogate Grammar School.

Some individuals on their team include Joel Pickering - President, TRX BioSurgery, Daniel Lee - President, US Operations, and Mike Izon - R&D Director.